Home / SmartTech / It's a new era for fertility technology – TechCrunch

It's a new era for fertility technology – TechCrunch

Women's Health has long since escaped technological innovation, but when it comes to fertility options, that is beginning to change. Startups in this area secure hundreds of millions of venture capital investments, significantly increasing the funds raised in recent years.

Fertility-centered entrepreneurs focus on a growing market: Couples prefer to multiply later in life. Number of female breadwinners can make their own decisions about when and how to reproduce and overall Today, around 10% of women in the US have difficulty getting an idea, such as the Centers for Disease Control and Prevention (19659002). Startups, as a result, are working to improve various points of pain on a fertility journey for women, whether inpatients New Age clinics, information platforms, mobile applications, wearables, direct medical tests or other tests.

] Although investment numbers are still relatively low (compared to scooters), the trend is up ̵

1; this is the latest information from founders and investors in space.

VCs Want to Help You're Getting Pregnant

Idea, an app to treat ovulation and ovulation, co-founder and CEO Ida Tin speaking at the TechCrunch Disrupt Berlin 2017 (Photo by Noam Galai / Getty Images for TechCrunch)

In TechCrunch got a tip this fall. SoftBank, a successful venture capital firm known for nearly $ 100 billion in its Vision Fund, invested in Glow, an app designed to track periods that help women become pregnant to become. Max Levchin, co-founder of Glow and a well-known member of PayPal Mafia, responded succinctly to a TechCrunch request for the deal via email: "Pretty sure you misunderstood this story," he wrote. Mike Huang, co-founder and chief executive officer of Glow, did not respond to several requests for comments at the time.

Needless to say, part of a SoftBank fertility agreement interested this reporter in an area that rarely populated tech blogs. 19659002] Femtech, a term coined by Ida Tin the founder of another time and the ovulation tracking app Clue, is defined as any software, diagnostic, products and services that enhance the health of technology Women uses. Femtech, and especially the fertility and contraceptive companies, have not made headlines as often as KI or Blockchain technologies. Probably because the companies in the industry have not completed so many notable venture accounts. It changes.

The global market for fertility services is expected to exceed $ 21 billion by 2020, according to Technavio. Meanwhile, private investment in the Femtech area in 2018 surpassed $ 400 million, after peaking at $ 354 million last year, according to data collected by PitchBook and Crunchbase. This year, several companies have entered into venture agreements, including Dadi men's fertility business and Extend Fertility, which help women freeze their eggs.

"Over the past three to six months, there has been a feeling that investor interest has gone through the roof." Jake Anderson-Bialis, co-founder of FertilityIQ and former investor at Sequoia Capital, said TechCrunch. "There are three to four e-mails a day. People come from the woodwork. It feels like someone shook the snow globe here and has not stopped for months.

Dadi, Extend Fertility, and FertilityIQ are among a growing list of fertility startups in recent years. FertilityIQ, in turn, provides a digital platform for fertility patients to examine and review physicians and clinics. The company also collects data and produces reports like these, which classify companies for fertility benefits. Anderson-Bialis launched the platform with his wife, co-founder Deborah Anderson-Bialis, in 2016, after the couple had overcome their own infertility issues.

Anderson-Bialis said he has recently submitted requests for seed, Series A and growth to investors interested in exploring the growing fertility market. However, his company has not borrowed. Why? He sees FertilityIQ not as a venture-scale company, but as a passion project and is skeptical of the real market opportunities for other companies in the world.

Source link